Orexigen Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2012.
URL: http://www.news-medical.net/news/20120807/Orexigen-Therapeutics-reports-net-loss-of-24167-million-for-second-quarter-2012.aspx
No comments:
Post a Comment